PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks.
about
MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activationPTOV1 enables the nuclear translocation and mitogenic activity of flotillin-1, a major protein of lipid raftsThe activator-recruited cofactor/Mediator coactivator subunit ARC92 is a functionally important target of the VP16 transcriptional activatorPTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycleMediator-dependent nuclear receptor functionStructure and VP16 binding of the Mediator Med25 activator interaction domainStructure of the VP16 transactivator target in the MediatorSolution NMR structure of MED25(391–543) comprising the activator-interacting domain (ACID) of human mediator subunit 25The role of prostate tumor overexpressed 1 in cancer progressionHDAC6 and Ubp-M BUZ domains recognize specific C-terminal sequences of proteins.Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer.Med25 is required for RNA polymerase II recruitment to specific promoters, thus regulating xenobiotic and lipid metabolism in human liver.Winter hibernation and UCHL1-p34cdc2 association in toad oocyte maturation competence.A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells.Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes.Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival.Synergistic activation of Arg1 gene by retinoic acid and IL-4 involves chromatin remodeling for transcription initiation and elongation couplingProstate tumor overexpressed-1, in conjunction with human papillomavirus status, predicts outcome in early-stage human laryngeal squamous cell carcinoma.Notch signaling in the prostate: critical roles during development and in the hallmarks of prostate cancer biology.Increased PTOV1 expression is related to poor prognosis in epithelial ovarian cancer.hnRNPK-regulated PTOV1-AS1 modulates heme oxygenase-1 expression via miR-1207-5p.Prostate tumour overexpressed-1 promotes tumourigenicity in human breast cancer via activation of Wnt/β-catenin signalling.Prostate tumor overexpressed 1 expression in invasive urothelial carcinoma.Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression.Regulation of protein translation and c-Jun expression by prostate tumor overexpressed 1.TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells.The extended AT-hook is a novel RNA binding motif.Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells.PTOV1 is associated with UCH-L1 and in response to estrogen stimuli during the mouse oocyte development.Overexpressed PTOV1 associates with tumorigenesis and progression of esophageal squamous cell carcinoma.PTOV1 is overexpressed in human high-grade malignant tumors
P2860
Q24321381-1C06BC18-F28A-402D-8310-02ECCAD7F0B2Q24556632-C9D45E24-9A88-4550-8D06-B3A4E8DE5401Q24622776-4E8A98CF-BB62-4247-A73B-8C6E4C9D4917Q24685775-D2D6A5BD-D123-4C0B-A056-19E652686576Q26995848-7A393116-3BEF-4E47-9CFD-FC4C5D0853B5Q27666881-AB8BF14D-3E82-4B80-82FC-6E1F46304163Q27667187-1994B0E8-8848-414C-995A-9886AB6EA62DQ27670982-85B52A27-51C7-4181-852A-EACC29BD7020Q28079350-465A1B5C-D487-458B-AB30-3B6AD913FD79Q33751395-4DE25B10-11AF-40D2-AD24-4C740F499752Q33804529-970AC350-67AB-44C1-A888-281E5896ED19Q34528349-FAAD4EA2-CAEF-47C7-96F9-DD1759E58BD3Q35032643-25B9955F-D766-4261-93E2-18094E8BDFADQ35692123-FC6DC1AE-3CCD-42DA-8953-D2F7DBB8F1A2Q35754655-DB6A47A8-DFF7-49FD-A898-AE1F015EC701Q36153245-44C9D6FA-E04B-4623-8242-C177727C38AEQ37264309-4A5CF3A6-88B7-438C-9222-1F40A40D6B7FQ37362545-FC20AE88-7050-4302-83EC-2A3F07A4BCD7Q38367417-5C7BC6FB-747B-4E7D-B06E-B1A82E891C13Q38389964-476154E7-19EC-461A-8D67-F625824532CBQ38754460-386F425E-4A6E-46CA-89BF-47A113FF49E0Q38779599-1F3DBA27-D751-427F-96B7-145E109A663AQ38922862-826FA057-BEC3-448A-967B-0C7847D4DD33Q39010024-1EAB86C2-5952-4D93-A056-3A1C94C56EDFQ39186150-215B7B88-E09B-4ED1-8A74-8659FBF1C664Q40720226-78B600DB-2B1B-4ABB-9D12-2FCBD9F3920CQ40756726-1792D0AC-3842-4DD4-8EA7-EF39C7D206CEQ41708911-B3012863-131A-4A08-ACFB-E0F8DCD94A24Q48670541-6AAF98DE-0125-432C-85BE-4F1F4B34DF90Q50922691-7D5E1457-1D13-4DD4-84BD-CE09F12510F6Q56999360-8EDCF179-1E05-4793-A14A-F25D05FBCD0F
P2860
PTOV1, a novel protein overexpressed in prostate cancer containing a new class of protein homology blocks.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
PTOV1, a novel protein overexp ...... ss of protein homology blocks.
@ast
PTOV1, a novel protein overexp ...... ss of protein homology blocks.
@en
type
label
PTOV1, a novel protein overexp ...... ss of protein homology blocks.
@ast
PTOV1, a novel protein overexp ...... ss of protein homology blocks.
@en
prefLabel
PTOV1, a novel protein overexp ...... ss of protein homology blocks.
@ast
PTOV1, a novel protein overexp ...... ss of protein homology blocks.
@en
P2093
P2860
P356
P1433
P1476
PTOV1, a novel protein overexp ...... ss of protein homology blocks.
@en
P2093
Paciucci R
Reventós J
Thomson TM
de Torres I
P2860
P2888
P304
P356
10.1038/SJ.ONC.1204233
P407
P577
2001-03-01T00:00:00Z
P5875
P6179
1021209523